Maricopa Integrated Health System Installs Masimo Patient SafetyNet™ System for Improved Oversight of General Floor Installation Is Part of an Organization-Wide Conversion to Masimo SET® Pulse Oximetry and rainbow® Pulse CO-Oximetry for Advanced Patient Monitoring
PHOENIX and IRVINE, Calif., Nov. 15, 2012 /PRNewswire/ --Maricopa Integrated Health System, among the most trafficked hospital systems in Arizona with more than 500 licensed beds, and Masimo (NASDAQ: MASI) today announced that Maricopa has deployed Masimo Patient SafetyNet™, clinically shown to help improve patient outcomes and save money.1
The installation is part of the nationally recognized healthcare organization's standardization to Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry and rainbow® SET® Pulse CO-Oximetry.
Maricopa joins a growing list of leading health systems using Patient SafetyNet, which can help ensure patient safety by noninvasively and continuously measuring and tracking their underlying physiological conditions and detect changes or abnormalities that signal declining health status in real-time. When changes occur in the measured values, which may indicate deterioration in the patient's condition, the system automatically sends wireless alerts directly to clinicians – prompting a potentially lifesaving response to the patient's bedside.
"Patients and their families can be confident that with the Masimo Patient SafetyNet system, they are being monitored at the bedside even when clinical staff is not in the room," said Michael O'Reilly, MD, Masimo's Chief Medical Officer. "We are honored that Maricopa Integrated Health System has selected Masimo technology to help protect their patients."
Maricopa patients also will benefit from breakthrough rainbow® technology that allows clinicians to measure multiple blood constituents, respiration rate, and other physiological parameters without invasive blood draws and time-consuming laboratory analysis. Parameters in use include total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to the Measure-Through Motion and Low Perfusion performance of Masimo SET® oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate (PR). The pulse oximetry standard-of-care at leading hospitals worldwide, Masimo SET® virtually eliminates false alarms2 and increases a clinician's ability to detect life-threatening events.3
Blood transfusions carry risks, including a significant link to mortality, infection, and adult respiratory distress syndrome.4 Masimo's SpHb has been clinically shown to help anesthesiologists reduce the frequency of blood transfusions.5
"I've found total hemoglobin (SpHb) to be particularly useful when I'm in the OR because it offers a continuous measurement," said William Johnson, MD, Chairman of the Department of Anesthesiology at Maricopa Medical Center. "In cases where there's insidious blood loss during some of the longer surgeries, you can keep track of the trend. And when there's relatively rapid loss, the Masimo monitor produces a graph to show hemoglobin falling. In either of those extremes, the ability to track blood loss may make you more inclined not to give a unit of blood when you can predict hemodynamics. When used properly, SpHb can reduce the urge to give blood when it's not absolutely necessary, which can improve patient safety and outcomes."
1 Taenzer A, Blike G, McGrath S, Pyke J, Herrick M, Renaud C, Morgan J. "Postoperative Monitoring – The Dartmouth Experience." Anesthesia Patient Safety Foundation Newsletter Spring-Summer 2012. Available online
2 Shah N, Ragaswamy H, Govindugari K, Estanol L. "Performance of three new-generation pulse oximeters during motion and low perfusion in volunteers." Journal of Clinical Anesthesia. 2012 (10.1016/j.jclinane.2011.10.012) Available online here
3 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue 2. Available online here
4 Marik, P. E. and H. L. Corwin (2008). "Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature." Crit Care Med 36(9): 2667-74.
5 Ehrenfeld JM, Henneman JP, Sandberg WS. "Impact of Continuous and Noninvasive Hemoglobin Monitoring on Intraoperative Blood Transfusions." American Society Anesthesiologists. 2010;LB05
About Maricopa Integrated Health System
Maricopa Integrated Health System (MIHS) is the public health care system for the State of Arizona. MIHS includes Maricopa Medical Center, the Arizona Burn Center, the Arizona Children's Center, the Arizona Cancer Center, and eleven Family Health Centers located throughout Maricopa County. MIHS also includes two behavioral health centers and an attendant care program. For more information, please visit www.mihs.org.
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care—helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOCTM), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com.
Forward Looking Statements
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions that the hospital-wide conversion ensures that all Maricopa Integrated Health System patients will be cared for using the most technologically and clinically-advanced noninvasive patient monitoring solutions available; risks related to our belief that Masimo Patient SafetyNet can help keep patients safer by noninvasively, continuously measuring and tracking their underlying physiological condition to help hospitals avoid preventable patient deaths and injuries associated with failure to rescue events, risks related to our assumptions of the repeatability of clinical results obtained, and risks related to the system's ability to significantly decrease traumatic critical events and costly ICU transfers to help improve patient outcomes and reduce costs; risks related to our belief that SpHb detects low or falling hemoglobin levels that could be the result of internal bleeding; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
Phone: (949) 297-7434
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, Adaptive Threshold Alarm, and SEDLine are trademarks or registered trademarks of Masimo Corporation. The use of the trademarks Patient SafetyNet and PSN is under license from University HealthSystem Consortium.